Metformin promotes innate immunity through a conserved PMK-1/p38 MAPK pathway

References

• Onken B, Driscoll M. Metformin induces a dietary restriction-like state and the oxidative stress response to extend C. elegans Healthspan via AMPK, LKB1, and SKN-1. PloS One. 2010;5:e8758.
   PubMedGoogle Scholar
• Cabreiro F, Au C, Leung KY, et al. Metformin retards aging in C. elegans by altering microbial folate and methionine metabolism. Cell. 2013;153:228–239.
   PubMed Web of Science ®Google Scholar
• Wu L, Zhou B, Oshiro-Rapley N, et al. An ancient, unified mechanism for metformin growth inhibition in C. elegans and cancer. Cell. 2016;167:1705–18 e13.
   PubMed Web of Science ®Google Scholar
• De Haes W, Frooninckx L, Van Assche R, et al. Metformin promotes lifespan through mitohormesis via the peroxiredoxin PRDX-2. Proc Natl Acad Sci U S A. 2014; 111:E2501–9.
   Google Scholar
• Chen J, Ou Y, Li Y, et al. Metformin extends C. elegans lifespan through lysosomal pathway. eLife. 2017;6:e31268.
   PubMed Web of Science ®Google Scholar
• Martin-Montalvo A, Mercken EM, Mitchell SJ, et al. Metformin improves healthspan and lifespan in mice. Nat Commun. 2013;4:2192.
   PubMed Web of Science ®Google Scholar
• Anisimov VN, Berstein LM, Egormin PA, et al. Metformin slows down aging and extends life span of female SHR mice. Cell Cycle. 2008;7:2769–2773.
   PubMed Web of Science ®Google Scholar
• Scarpello JH. Improving survival with metformin: the evidence base today. Diabetes Metab. 2003;29:6S36–43.
   PubMed Web of Science ®Google Scholar
• Dowling RJ, Goodwin PJ, Stambolic V. Understanding the benefit of metformin use in cancer treatment. BMC Med. 2011;9:33.
   PubMed Web of Science ®Google Scholar
• Foretz M, Guigas B, Bertrand L, et al. Metformin: from mechanisms of action to therapies. Cell Metab. 2014;20:953–966.
   PubMed Web of Science ®Google Scholar
• Othman AA, Abou Rayia DM, Ashour DS, et al. Atorvastatin and metformin administration modulates experimental Trichinella spiralis infection. Parasitol Int. 2016;65:105–112.
   PubMed Web of Science ®Google Scholar
• Garnett JP, Baker EH, Naik S, et al. Metformin reduces airway glucose permeability and hyperglycaemia-induced Staphylococcus aureus load independently of effects on blood glucose. Thorax. 2013;68:835–845.
   PubMed Web of Science ®Google Scholar
• Patkee WR, Carr G, Baker EH, et al. Metformin prevents the effects of Pseudomonas aeruginosa on airway epithelial tight junctions and restricts hyperglycaemia-induced bacterial growth. J Cell Mol Med. 2016;20:758–764.
   PubMed Web of Science ®Google Scholar
• Tzanavari T, Varela A, Theocharis S, et al. Metformin protects against infection-induced myocardial dysfunction. Metabolism. 2016;65:1447–1458.
   PubMed Web of Science ®Google Scholar
• Xun YH, Zhang YJ, Pan QC, et al. Metformin inhibits hepatitis B virus protein production and replication in human hepatoma cells. J Viral Hepat. 2014;21:597–603.
   PubMed Web of Science ®Google Scholar
• Yu JW, Sun LJ, Liu W, et al. Hepatitis C virus core protein induces hepatic metabolism disorders through down-regulation of the SIRT1-AMPK signaling pathway. Int J Infect Dis. 2013;17:e539–45.
   PubMed Web of Science ®Google Scholar
• Hsu CS, Hsu SJ, Lin HH, et al. A pilot study of add-on oral hypoglycemic agents in treatment-naive genotype-1 chronic hepatitis C patients receiving peginterferon alfa-2b plus ribavirin. J Formos Med Assoc. 2014;113:716–721.
   PubMed Web of Science ®Google Scholar
• Fitch K, Abbara S, Lee H, et al. Effects of lifestyle modification and metformin on atherosclerotic indices among HIV-infected patients with the metabolic syndrome. Aids. 2012;26:587–597.
   PubMed Web of Science ®Google Scholar
• Malik F, Mehdi SF, Ali H, et al. Is metformin poised for a second career as an antimicrobial? Diabetes Metab Res Rev. 2018;34:e2975.
   PubMed Web of Science ®Google Scholar
• Shaw RJ, Lamia KA, Vasquez D, et al. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science. 2005;310:1642–1646.
   PubMed Web of Science ®Google Scholar
• Zhou G, Myers R, Li Y, et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest. 2001;108:1167–1174.
   PubMed Web of Science ®Google Scholar
• Singhal A, Jie L, Kumar P, et al. Metformin as adjunct antituberculosis therapy. Sci Transl Med. 2014;6:263ra159.
   PubMed Web of Science ®Google Scholar
• Madiraju AK, Erion DM, Rahimi Y, et al. Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase. Nature. 2014;510:542–546.
   PubMed Web of Science ®Google Scholar
• Vashisht R, Brahmachari SK. Metformin as a potential combination therapy with existing front-line antibiotics for Tuberculosis. J Transl Med. 2015;13:83.
   PubMed Web of Science ®Google Scholar
• Kane DA, Anderson EJ, Price JW 3rd, et al. Metformin selectively attenuates mitochondrial H2O2 emission without affecting respiratory capacity in skeletal muscle of obese rats. Free Radic Biol Med. 2010;49:1082–1087.
   PubMed Web of Science ®Google Scholar
• Aballay A, Ausubel FM. Caenorhabditis elegans as a host for the study of host-pathogen interactions. Curr Opin Microbiol. 2002;5:97–101.
   PubMed Web of Science ®Google Scholar
• Xiao Y, Liu F, Zhao PJ, et al. PKA/KIN-1 mediates innate immune responses to bacterial pathogens in Caenorhabditis elegans. Innate Immun. 2017;23:656–666.
   PubMed Web of Science ®Google Scholar
• Irazoqui JE, Urbach JM, Ausubel FM. Evolution of host innate defence: insights from Caenorhabditis elegans and primitive invertebrates. Nat Rev Immunol. 2010;10:47–58.
   PubMed Web of Science ®Google Scholar
• Kim D. Studying host-pathogen interactions and innate immunity in Caenorhabditis elegans. Dis Model Mech. 2008;1:205–208.
   PubMed Web of Science ®Google Scholar
• Kurz CL, Ewbank JJ. Caenorhabditis elegans: an emerging genetic model for the study of innate immunity. Nat Rev Genet. 2003;4:380–390.
   PubMed Web of Science ®Google Scholar
• Kim DH, Feinbaum R, Alloing G, et al. A conserved p38 MAP kinase pathway in Caenorhabditis elegans innate immunity. Science. 2002;297:623–626.
   PubMed Web of Science ®Google Scholar
• Aballay A, Drenkard E, Hilbun LR, et al. Caenorhabditis elegans innate immune response triggered by Salmonella enterica requires intact LPS and is mediated by a MAPK signaling pathway. Curr Biol. 2003;13:47–52.
   PubMed Web of Science ®Google Scholar
• Garsin DA, Villanueva JM, Begun J, et al. Long-lived C. elegans daf-2 mutants are resistant to bacterial pathogens. Science. 2003;300:1921.
   PubMed Web of Science ®Google Scholar
• Nicholas HR, Hodgkin J. The ERK MAP kinase cascade mediates tail swelling and a protective response to rectal infection in C. elegans. Curr Biol. 2004;14:1256–1261.
   PubMed Web of Science ®Google Scholar
• Ren M, Feng H, Fu Y, et al. Protein kinase D is an essential regulator of C. elegans innate immunity. Immunity. 2009;30:521–532.
   PubMed Web of Science ®Google Scholar
• Powell JR, Kim DH, Ausubel FM The G protein-coupled receptor FSHR-1 is required for the Caenorhabditis elegans innate immune response. Proc Natl Acad Sci U S A. 2009; 106:2782–2787.
   Google Scholar
• Kawli T, Wu C, Tan MW Systemic and cell intrinsic roles of Gqalpha signaling in the regulation of innate immunity, oxidative stress, and longevity in Caenorhabditis elegans. Proc Natl Acad Sci U S A. 2010; 107:13788–13793.
   Google Scholar
• Tan MW, Rahme LG, Sternberg JA, et al. Pseudomonas aeruginosa killing of Caenorhabditis elegans used to identify P. aeruginosa virulence factors. Proc Natl Acad Sci U S A. 1999; 96:2408–2413.
   Google Scholar
• Sun J, Singh V, Kajino-Sakamoto R, et al. Neuronal GPCR controls innate immunity by regulating noncanonical unfolded protein response genes. Science. 2011;332:729–732.
   PubMed Web of Science ®Google Scholar
• Fuhrman LE, Goel AK, Smith J, et al. Nucleolar proteins suppress Caenorhabditis elegans innate immunity by inhibiting p53/CEP-1. PLoS Genet. 2009;5:e1000657.
   PubMed Web of Science ®Google Scholar
• Kim DH, Liberati NT, Mizuno T, et al. Integration of Caenorhabditis elegans MAPK pathways mediating immunity and stress resistance by MEK-1 MAPK kinase and VHP-1 MAPK phosphatase. Proc Natl Acad Sci U S A. 2004; 101:10990–10994.
   Google Scholar
• Ren Z, Ambros VR Caenorhabditis elegans microRNAs of the let-7 family act in innate immune response circuits and confer robust developmental timing against pathogen stress. Proc Natl Acad Sci U S A. 2015; 112:E2366–75.
   Google Scholar
• Cao X, Aballay A. Neural inhibition of dopaminergic signaling enhances immunity in a cell-non-autonomous manner. Curr Biol. 2016;26:2329–2334.
   PubMed Web of Science ®Google Scholar
• Melo JA, Ruvkun G. Inactivation of conserved C. elegans genes engages pathogen- and xenobiotic-associated defenses. Cell. 2012;149:452–466.
   PubMed Web of Science ®Google Scholar
• Qadota H, Inoue M, Hikita T, et al. Establishment of a tissue-specific RNAi system in C. elegans. Gene. 2007;400:166–173.
   PubMed Web of Science ®Google Scholar
• Calixto A, Chelur D, Topalidou I, et al. Enhanced neuronal RNAi in C. elegans using SID-1. Nat Methods. 2010;7:554–559.
   PubMed Web of Science ®Google Scholar
• Grossi V, Liuzzi M, Murzilli S, et al. Sorafenib inhibits p38alpha activity in colorectal cancer cells and synergizes with the DFG-in inhibitor SB202190 to increase apoptotic response. Cancer Biol Ther. 2012;13:1471–1481.
   PubMed Web of Science ®Google Scholar
• Tauber SC, Nau R. Immunomodulatory properties of antibiotics. Curr Mol Pharmacol. 2008;1:68–79.
   PubMedGoogle Scholar
• Cai Y, Cao X, Aballay A. Whole-animal chemical screen identifies colistin as a new immunomodulator that targets conserved pathways. mBio. 2014;5:e01235-14.
   Web of Science ®Google Scholar
• Rubin BK, Henke MO. Immunomodulatory activity and effectiveness of macrolides in chronic airway disease. Chest. 2004;125:70S–8S.
   PubMed Web of Science ®Google Scholar
• Saiman L, Marshall BC, Mayer-Hamblett N, et al. Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial. Jama. 2003;290:1749–1756.
   PubMed Web of Science ®Google Scholar
• Brenner S. The genetics of Caenorhabditis elegans. Genetics. 1974;77:71–94.
   PubMed Web of Science ®Google Scholar
• Stiernagle T. Maintenance of C. elegans. In: Fay D, editor. WormBook. 2006. p. 1–11.
   Google Scholar
• Kamath RS, Ahringer J. Genome-wide RNAi screening in Caenorhabditis elegans. Methods. 2003;30:313–321.
   PubMed Web of Science ®Google Scholar
• Lapierre LR, De Magalhaes Filho CD, McQuary PR, et al. The TFEB orthologue HLH-30 regulates autophagy and modulates longevity in Caenorhabditis elegans. Nat Commun. 2013;4:2267.
   PubMed Web of Science ®Google Scholar
• Facchini M, De Fino I, Riva C, et al. Long term chronic Pseudomonas aeruginosa airway infection in mice. J Vis Exp. 2014:e51019.
   PubMed Web of Science ®Google Scholar